12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry. He believes in the ‘transformation’ the pharma and biotech industries are going through. While he completely supports the new, he is a strong advocate of getting the basics right.

What are the main responsibilities of your current role?

Managing director of PurpleLeaf Strategy, which also includes a lot of client-facing project management and new product development.

What is your background prior to this role and how did it prepare you for the work you do now?

I’ve been in pharma since 2005, when I started to carry the bag for Gruenenthal Germany. My career in pharma included junior product management to group product management, global marketing excellence, global commercial effectiveness, global brand director, etc., in mid to big pharma companies, such as Solvay, Abbott, and Roche. I learned pharma sales and marketing from the beginning and was lucky being exposed to challenges in multiple country healthcare systems over a considerable time. I’ve developed multiple brand strategy processes, which let me end up in my current role.

• Read the full article in pharmaphorum's Deep Dive digital magazine